Eli Lilly (LLY) EBIT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
80.35% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.93% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
6.88% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-411.15% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
126.32% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-0.98% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-193.55% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
80.35% |
| Dec 31, 2025 |
66.80% |
| Sep 30, 2025 |
84.28% |
| Jun 30, 2025 |
81.46% |
| Mar 31, 2025 |
101.07% |
| Dec 31, 2024 |
77.35% |
| Sep 30, 2024 |
27.07% |
| Jun 30, 2024 |
74.06% |
| Mar 31, 2024 |
63.82% |
| Dec 31, 2023 |
44.94% |
| Sep 30, 2023 |
96.99% |
| Jun 30, 2023 |
34.67% |
| Mar 31, 2023 |
-37.78% |
| Dec 31, 2022 |
-11.82% |
| Sep 30, 2022 |
-15.54% |
| Jun 30, 2022 |
14.13% |
| Mar 31, 2022 |
75.14% |
| Dec 31, 2021 |
-4.57% |
| Sep 30, 2021 |
61.06% |
| Jun 30, 2021 |
0.53% |
| Mar 31, 2021 |
-10.70% |
| Dec 31, 2020 |
59.02% |
| Sep 30, 2020 |
-15.25% |
| Jun 30, 2020 |
-5.56% |
| Mar 31, 2020 |
36.26% |
| Dec 31, 2019 |
9.12% |
| Sep 30, 2019 |
6.53% |
| Jun 30, 2019 |
-4.44% |
| Mar 31, 2019 |
-10.87% |
| Dec 31, 2018 |
16.06% |
| Sep 30, 2018 |
22.78% |
| Jun 30, 2018 |
27.52% |
| Mar 31, 2018 |
28.32% |
| Dec 31, 2017 |
16.28% |
| Sep 30, 2017 |
16.60% |
| Jun 30, 2017 |
27.39% |
| Mar 31, 2017 |
24.46% |
| Dec 31, 2016 |
41.68% |
| Sep 30, 2016 |
-1.46% |
| Jun 30, 2016 |
2.71% |
| Mar 31, 2016 |
-4.72% |
| Dec 31, 2015 |
-15.73% |
| Sep 30, 2015 |
44.77% |
| Jun 30, 2015 |
7.76% |
| Mar 31, 2015 |
2.66% |
| Dec 31, 2014 |
-11.14% |
| Sep 30, 2014 |
-55.12% |
| Jun 30, 2014 |
-43.40% |
| Mar 31, 2014 |
-40.00% |
| Dec 31, 2013 |
-21.69% |
| Sep 30, 2013 |
35.56% |
| Jun 30, 2013 |
30.30% |
| Mar 31, 2013 |
2.74% |
| Dec 31, 2012 |
18.70% |
| Sep 30, 2012 |
-28.15% |
| Jun 30, 2012 |
-24.34% |
| Mar 31, 2012 |
-16.02% |
| Dec 31, 2011 |
-26.25% |
| Sep 30, 2011 |
3.99% |
| Jun 30, 2011 |
-0.41% |
| Mar 31, 2011 |
-0.61% |
| Dec 31, 2010 |
11.89% |
| Sep 30, 2010 |
58.87% |
| Jun 30, 2010 |
6.95% |
| Mar 31, 2010 |
-4.04% |
